Purple Biotech Ltd. (PPBT)
NASDAQ·Healthcare·Biotechnology
$4.54
-1.02%
Mkt Cap $626.90K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | — | — | — | -$3.40 | -$19.85 | -483.82% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.26 | -$0.29 | -11.54% | — | — |
| Q3 2025 Aug 6, 2025 | — | — | — | -$0.21 | -$0.40 | -90.48% | — | — |
| Q2 2025 May 21, 2025 | — | — | — | — | -$0.17 | — | — | — |
| Q1 2025 Mar 10, 2025 | — | — | — | -$0.22 | -$0.26 | -18.18% | — | — |
| Q4 2024 Nov 15, 2024 | — | — | — | -$1.20 | -$1.37 | -14.17% | — | — |
| Q3 2024 Aug 16, 2024 | — | — | — | -$0.16 | -$1.60 | -900.00% | — | — |
| Q2 2024 May 21, 2024 | — | — | — | -$3.00 | -$3.00 | +0.00% | — | — |
| Q1 2024 Mar 5, 2024 | — | — | — | -$3.40 | -$6.40 | -88.24% | — | — |
| Q4 2023 Nov 21, 2023 | — | — | — | -$4.40 | -$4.20 | +4.55% | — | — |
| Q3 2023 Aug 22, 2023 | — | — | — | -$5.00 | -$4.60 | +8.00% | — | — |
| Q2 2023 May 16, 2023 | — | — | — | -$7.00 | -$4.20 | +40.00% | — | — |
| Q1 2023 Feb 8, 2023 | — | — | — | -$6.00 | -$6.00 | +0.00% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.21 | -$0.27 | -28.57% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | — | -$39.33 | — | — | — |
| Q2 2022 May 12, 2022 | — | — | — | — | -$81.93 | — | — | — |
| Q1 2022 Feb 9, 2022 | — | — | — | — | -$18186.10 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$35.83 | — | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$0.01 | -$41.39 | -413814.00% | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$75.35 | — | — | — |